Repligen
RGEN
431 hedge funds and large institutions have $8.09B invested in Repligen in 2024 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 136 increasing their positions, 159 reducing their positions, and 67 closing their positions.
1.37% more ownership
Funds ownership: 99.01% → 100.37% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $8.24B → $8.09B (-$150M)
3% less funds holding
Funds holding: 444 → 431 (-13)
10% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 67
14% less repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 159
47% less call options, than puts
Call options by funds: $40.1M | Put options by funds: $75.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$107M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$95.2M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$85.2M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$53.2M |
| 5 |
Holocene Advisors
New York
|
+$44.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
-$82.6M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$45.4M |
| 3 |
BlackRock
New York
|
-$35.9M |
| 4 |
JP Morgan Chase
New York
|
-$29M |
| 5 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$23.6M |
RGEN Hedge Fund Activity: Q4 2024 in Review
431 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q4 2024, worth a combined $8.09B — down 1.8% from $8.24B a quarter earlier.
Sellers outnumbered buyers: 67 funds closed out of RGEN and 60 opened new positions — a net loss of 7 holders — while 159 trimmed existing stakes and 136 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $107M. The largest seller was Harding Loevner, cutting an estimated $82.6M.
- 431 institutional investors held Repligen (RGEN) as of Q4 2024, down from 444 in Q3 2024.
- Funds reported $8.09B of Repligen stock for Q4 2024, down 1.8% quarter-over-quarter.
- 60 funds opened new Repligen positions in Q4 2024 and 67 closed out, a net change of -7 holders.
- The largest Repligen buyer in Q4 2024 was T. Rowe Price Associates, an estimated $107M added.
- The largest Repligen seller in Q4 2024 was Harding Loevner, an estimated $82.6M sold.
Based on aggregated 13F filings for Q4 2024.